disufenton sodium has been researched along with Hyperglycemia, Postprandial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dávalos, A; Ferro, JM | 1 |
Alderfer, V; Ashwood, T; Davalos, A; Davis, SM; Diener, HC; Grotta, J; HÃ¥rdemark, HG; Lees, KR; Lyden, P; Rodichok, L; Shuaib, A; Wasiewski, W | 1 |
1 trial(s) available for disufenton sodium and Hyperglycemia, Postprandial
Article | Year |
---|---|
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Topics: Age Factors; Aged; Antioxidants; Benzenesulfonates; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebral Infarction; Comorbidity; Double-Blind Method; Drug Administration Schedule; Emergency Medical Services; Encephalitis; Female; Humans; Hyperglycemia; Injections, Intravenous; Male; Meta-Analysis as Topic; Middle Aged; Neuroprotective Agents; Placebos; Prognosis; Stroke; Treatment Failure | 2008 |
1 other study(ies) available for disufenton sodium and Hyperglycemia, Postprandial
Article | Year |
---|---|
Other neuroprotective therapies on trial in acute stroke.
Topics: Anti-Inflammatory Agents; Benzenesulfonates; Drug Combinations; Free Radical Scavengers; Glucose; Hemorrhage; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Interferon beta-1a; Interferon-beta; Neuroprotective Agents; Potassium; Randomized Controlled Trials as Topic; Recombinant Proteins; Stroke; Tissue Plasminogen Activator | 2006 |